Dr. Macone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany St
# Shapiro
Boston, MA 02118Phone+1 617-638-8456Fax+1 617-638-8465
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Headache Medicine, 2018 - 2020
- Boston University Medical CenterResidency, Neurology, 2015 - 2018
- Tufts University School of MedicineClass of 2014
Certifications & Licensure
- MA State Medical License 2019 - 2026
- NH State Medical License 2018 - 2026
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Scoping Review: The Effects of Interrupted Onabotulinumtoxin A Treatment for Chronic Migraine Prevention During the COVID-19 Pandemic.Qing Zhao Ruan, Daniel J Pak, Amitabh Gulati, Moises Dominguez, Sudhir Diwan
Journal of Pain Research. 2024-01-01 - 4 citationsRapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.Anna M. Cervantes-Arslanian, K. H. Vincent Lau, Pria Anand, Julie G. Shulman, Thomas Ford
Annals of Neurology. 2020-08-01 - 4 citationsLasmiditan: Its Development and Potential Use.Amanda E. Macone, Michael D. Perloff
Clinical Pharmacology in Drug Development. 2020-04-01
Journal Articles
- Calcitonin Gene Related Peptide: The New Era of Migraine Therapy5. Macone A; Tepper SJ, Future Drug Discovery, 2019
Research History
- Principle InvestigatorHeadache Characteristics in COVID-192020 - Present
Professional Memberships
- American Headache SocietyMember
- Headache Cooperative of New EnglandMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: